Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-18 4:30 pm Unchanged |
2025-02-10 | 13G | Biodexa Pharmaceuticals Plc BDRX |
C/M Capital Master Fund, LP | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-11-20 11:56 am Purchase |
2024-11-14 | 13G | Biodexa Pharmaceuticals Plc BDRX |
Brio Capital Master Fund Ltd. | 167,681 0.900% |
110,567 (+193.59%) |
Filing History |
| 2024-11-14 5:12 pm Sale |
2024-09-30 | 13G | Biodexa Pharmaceuticals Plc BDRX |
Iroquois Capital Management, LLC | 112,077 0.670% |
-44,718,963 (-99.75%) |
Filing History |
| 2024-11-12 4:30 pm Purchase |
2024-09-30 | 13G | Biodexa Pharmaceuticals Plc BDRX |
Bigger Capital LLC | 69,260,800 11.000% |
59,595,424 (+616.59%) |
Filing History |
| 2024-11-07 4:51 pm Sale |
2024-09-30 | 13G | Biodexa Pharmaceuticals Plc BDRX |
Cavalry Fund I LP | 0 0.000% |
-4,647,807 (Position Closed) |
Filing History |
| 2024-08-08 4:24 pm Purchase |
2024-07-19 | 13G | Biodexa Pharmaceuticals Plc BDRX |
Iroquois Capital Management, LLC | 44,831,040 9.990% |
44,831,040 (New Position) |
Filing History |
| 2024-07-23 3:09 pm Purchase |
2024-07-15 | 13G | Biodexa Pharmaceuticals Plc BDRX |
Brio Capital Master Fund Ltd. | 57,114 9.830% |
57,114 (New Position) |
Filing History |
| 2024-02-14 8:47 pm Purchase |
2023-12-31 | 13G | Biodexa Pharmaceuticals Plc BDRX |
Ionic Ventures LLC | 5,421 4.900% |
5,421 (New Position) |
Filing History |
| 2024-02-14 2:42 pm Purchase |
2023-12-31 | 13G | Biodexa Pharmaceuticals Plc BDRX |
Armistice Capital, LLC | 998 0.940% |
998 (New Position) |
Filing History |
| 2024-02-14 2:14 pm Unchanged |
2023-12-31 | 13G | Biodexa Pharmaceuticals Plc BDRX |
CVI Investments, Inc. | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-02-13 4:33 pm Purchase |
2023-12-31 | 13G | Biodexa Pharmaceuticals Plc BDRX |
Cavalry Fund I LP | 4,647,807 9.900% |
225,487 (+5.10%) |
Filing History |
| 2024-02-12 4:30 pm Purchase |
2023-12-21 | 13G | Biodexa Pharmaceuticals Plc BDRX |
Bigger Capital LLC | 9,665,376 9.900% |
9,665,376 (New Position) |
Filing History |
| 2024-01-08 4:01 pm Purchase |
2023-12-21 | 13G | Biodexa Pharmaceuticals Plc BDRX |
Mercer Street Global Opportunity Fund LLC | 4,375,872 9.990% |
4,375,872 (New Position) |
Filing History |
| 2023-12-28 4:30 pm Purchase |
2023-12-21 | 13G | Biodexa Pharmaceuticals Plc BDRX |
Cavalry Fund I LP | 4,422,320 9.900% |
4,422,320 (New Position) |
Filing History |
| 2023-03-06 06:01 am Purchase |
2023-02-15 | 13G | Midatech Pharma plc MTP |
Ionic Ventures LLC | 4,509,231 9.990% |
4,509,231 (New Position) |
Filing History |
| 2023-02-21 11:10 am Purchase |
2023-02-09 | 13G | Midatech Pharma plc MTP |
CVI Investments, Inc. | 2,708,500 6.200% |
2,708,500 (New Position) |
Filing History |
| 2023-02-14 1:50 pm Purchase |
2022-12-31 | 13G | Midatech Pharma plc MTP |
Armistice Capital, LLC | 96,707 8.930% |
96,707 (New Position) |
Filing History |
| 2020-07-10 10:48 am Sale |
2020-06-30 | 13G | Biodexa Pharmaceuticals Plc BDRX |
BlackRock Inc. BLK |
23 1.900% |
-74 (-76.44%) |
Filing |
| 2020-06-09 4:52 pm Sale |
2020-05-31 | 13G | Biodexa Pharmaceuticals Plc BDRX |
BlackRock Inc. BLK |
97 9.900% |
-1,871 (-95.06%) |
Filing |